7 withdrawn. 7 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Withdrawn 7 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Heroin Dependence: new trials by email Literature Review of Heroin Dependence trials Research Report on Heroin Dependence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India Directly Administered Antiretroviral Therapy (DAART), SAT - HIV Infections, Heroin Dependence | Phase 2 / Phase 3 | Withdrawn | Johns Hopkins University | 2008-07-01 | 2015-04-15 | |
| Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6 Test Drug, Placebo Drug - Heroin Dependence, Opioid-Related Disorders | Phase 2 | Withdrawn | University of Colorado, Denver | 2002-12-01 | 2017-05-04 | |
| Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5 Opioid-Related Disorders - Heroin Dependence, Opioid-Related Disorders | Phase 2 | Withdrawn | University of Colorado, Denver | 1999-10-01 | 2017-05-04 | |
| Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4 Opioid-Related Disorders - Heroin Dependence, Opioid-Related Disorders | Phase 2 | Withdrawn | University of Colorado, Denver | 1999-04-01 | 2017-05-04 | |
| Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3 Opioid-Related Disorders - Heroin Dependence, Opioid-Related Disorders | Phase 2 | Withdrawn | University of Colorado, Denver | 1997-07-01 | 2017-05-04 | |
| Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2 Heroin Dependence - Heroin Dependence, Opioid-Related Disorders | Phase 2 | Withdrawn | University of Colorado, Denver | 1997-06-01 | 2017-05-04 | |
| Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1 Heroin Dependence - Heroin Dependence, Opioid-Related Disorders | Phase 2 | Withdrawn | University of Colorado, Denver | 1997-04-01 | 2017-05-04 |
Opioid-Related Disorders (6) · Substance-Related Disorders (3) · HIV Infections (1)
Chemically-Induced Disorders (7) · Mental Disorders (7) · Narcotic-Related Disorders (7) · Substance-Related Disorders (4) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1) · Lentivirus Infections (1) · Opioid-Related Disorders (1) · RNA Virus Infections (1) · Retroviridae Infections (1) · Sexually Transmitted Diseases (1)
Drug Evaluation (1)
University of Colorado, Denver (6) · Johns Hopkins University (1)
United States (6) · India (1)
Leslie Amass, Ph.D. (6) · Gregory M Lucas, MD,PhD (1)
R01DA011160 (6)